emapalumab-lzsg (gamifant) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Priority Review FDA

Active Ingredient History

  • Now
Emapalumab, sold under the brand name Gamifant, is an anti-interferon-gamma (IFNγ) antibody medication used for the treatment of hemophagocytic lymphohistiocytosis (HLH), which has no cure.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Drug Pricing (per unit)

United States

$5187.4600 - $16630.5000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

emapalumab-lzsg | ni-0501


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue